{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:05:23Z","timestamp":1791515123933,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873882"],"award-info":[{"award-number":["81873882"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.intimp.2023.109720","type":"journal-article","created":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T10:15:01Z","timestamp":1674296101000},"page":"109720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Zingerone attenuates Ti particle-induced inflammatory osteolysis by suppressing the NF-\u03baB signaling pathway in osteoclasts"],"prefix":"10.1016","volume":"115","author":[{"given":"Daishui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.109720_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092073","article-title":"Osteoblast-osteoclast communication and bone homeostasis","volume":"9","author":"Kim","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2023.109720_b0010","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bbrc.2020.07.083","article-title":"Tussilagone promotes osteoclast apoptosis and prevents estrogen deficiency-induced osteoporosis in mice","volume":"531","author":"Ryoo","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2023.109720_b0015","unstructured":"T. Nakashima, M. Hayashi, H. Takayanagi, [Bone and calcium update; bone research update. Osteoclastogenesis and osteoimmunology], Clinical calcium 21 (2011) 93\u2013102, <https:\/\/doi.org\/CliCa111218431852>."},{"key":"10.1016\/j.intimp.2023.109720_b0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bone.2010.08.004","article-title":"TGF-\u03b2 in cancer and bone: implications for treatment of bone metastases","volume":"48","author":"Ju\u00e1rez","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.intimp.2023.109720_b0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fphar.2020.00385","article-title":"Tussilagone inhibits osteoclastogenesis and periprosthetic osteolysis by suppressing the NF-\u03baB and P38 MAPK signaling pathways","volume":"11","author":"Hu","year":"2020","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.intimp.2023.109720_b0030","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10787-013-0192-6","article-title":"Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management","volume":"21","author":"Howie","year":"2013","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2023.109720_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121127","article-title":"Aseptic and septic prosthetic joint loosening: impact of biomaterial wear on immune cell function, inflammation, and infection","volume":"278","author":"Hodges","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2023.109720_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8122091","article-title":"Periprosthetic osteolysis: mechanisms, prevention and treatment","volume":"8","author":"Goodman","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2023.109720_b0045","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2106\/JBJS.18.01218","article-title":"Long-term survivorship of total hip arthroplasty with highly cross-linked polyethylene for osteonecrosis","volume":"101","author":"Hart","year":"2019","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.intimp.2023.109720_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.869422","article-title":"The role of BMPs in the regulation of osteoclasts resorption and bone remodeling: from experimental models to clinical applications","volume":"13","author":"Bordukalo-Nik\u0161i\u0107","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2023.109720_b0055","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1177\/0022034513500306","article-title":"Advances in the regulation of osteoclasts and osteoclast functions","volume":"92","author":"Boyce","year":"2013","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.intimp.2023.109720_b0060","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw6143","article-title":"Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases","volume":"12","author":"Zhu","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2023.109720_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/cells11010013","article-title":"The cytoplasmic dynein associated protein NDE1 regulates osteoclastogenesis by modulating M-CSF and RANKL signaling pathways","volume":"11","author":"Das","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2023.109720_b0070","doi-asserted-by":"crossref","DOI":"10.3791\/55025-v","article-title":"Drug treatment and in vivo imaging of osteoblast-osteoclast interactions in a medaka fish osteoporosis model","author":"Yu","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.intimp.2023.109720_b0075","article-title":"Punicalin attenuates breast cancer-associated osteolysis by inhibiting the NF-\u03baB signaling pathway of osteoclasts","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.intimp.2023.109720_b0080","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2741\/2252","article-title":"Osteoclast differentiation and gene regulation","volume":"12","author":"Zhao","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.intimp.2023.109720_b0085","doi-asserted-by":"crossref","first-page":"17109","DOI":"10.1038\/nplants.2017.109","article-title":"Demystifying traditional herbal medicine with modern approach","volume":"3","author":"Li","year":"2017","journal-title":"Nat. Plants"},{"key":"10.1016\/j.intimp.2023.109720_b0090","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/816364","article-title":"A review on pharmacological properties of zingerone (4-(4-hydroxy-3-methoxyphenyl)-2-butanone)","volume":"2015","author":"Ahmad","year":"2015","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.intimp.2023.109720_b0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/13510002.2021.1907518","article-title":"Zingerone (4-(four-hydroxy-3-methylphenyl) butane-two-1) modulates adjuvant-induced rheumatoid arthritis by regulating inflammatory cytokines and antioxidants","volume":"26","author":"Bashir","year":"2021","journal-title":"Redox Rep."},{"key":"10.1016\/j.intimp.2023.109720_b0100","first-page":"303","article-title":"Zingerone improves the immune responses in an animal model of breast cancer","volume":"18","author":"Kazemi","year":"2021","journal-title":"J. Compl. Integr. Med."},{"key":"10.1016\/j.intimp.2023.109720_b0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.intimp.2013.12.028","article-title":"Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice","volume":"19","author":"Xie","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.109720_b0110","first-page":"268","article-title":"Suppression of cartilage degradation by zingerone involving the p38 and JNK MAPK signaling pathway","volume":"83","author":"Ruangsuriya","year":"2017","journal-title":"Planta Med."},{"key":"10.1016\/j.intimp.2023.109720_b0115","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3389\/fphar.2018.01028","article-title":"Hesperetin prevents bone resorption by inhibiting RANKL-induced osteoclastogenesis and Jnk Mediated Irf-3\/c-Jun activation","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.intimp.2023.109720_b0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1749-6632.2011.06283.x","article-title":"The osteoclast and its unique cytoskeleton","volume":"1240","author":"Teitelbaum","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.intimp.2023.109720_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106847","article-title":"Melatonin suppresses Ti-particle-induced inflammatory osteolysis via activation of the Nrf2\/Catalase signaling pathway","volume":"88","author":"Zhu","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"Suppl","key":"10.1016\/j.intimp.2023.109720_b0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF03026317","article-title":"Roles for NF-kappaB and c-Fos in osteoclasts","volume":"23","author":"Boyce","year":"2005","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.intimp.2023.109720_b0135","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.bbrc.2012.12.051","article-title":"Sanguinarine inhibits osteoclast formation and bone resorption via suppressing RANKL-induced activation of NF-\u03baB and ERK signaling pathways","volume":"430","author":"Li","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2023.109720_b0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cbi.2017.11.004","article-title":"Zingerone protects keratinocyte stem cells from UVB-induced damage","volume":"279","author":"Lee","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.intimp.2023.109720_b0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1210\/er.2010-0006","article-title":"Osteoclast activity and subtypes as a function of physiology and pathology\u2013implications for future treatments of osteoporosis","volume":"32","author":"Henriksen","year":"2011","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.intimp.2023.109720_b0150","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1302\/0301-620X.95B11.32644","article-title":"Osteonecrosis of the femoral head: the total hip replacement solution","volume":"95-B","author":"Issa","year":"2013","journal-title":"Bone Joint J."},{"key":"10.1016\/j.intimp.2023.109720_b0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/BOT.0000000000000291","article-title":"Femoral neck fractures: current management","volume":"29","author":"Florschutz","year":"2015","journal-title":"J. Orthop. Trauma"},{"key":"10.1016\/j.intimp.2023.109720_b0160","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.arth.2013.01.012","article-title":"Revision surgery after total joint arthroplasty: a complication-based analysis using worldwide arthroplasty registers","volume":"28","author":"Sadoghi","year":"2013","journal-title":"J. Arthroplast."},{"key":"10.1016\/j.intimp.2023.109720_b0165","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1016\/j.arth.2020.06.069","article-title":"Thirty-day readmissions after aseptic revision total hip arthroplasty: rates, predictors, and reasons vary by surgical indication","volume":"35","author":"Pathak","year":"2020","journal-title":"J. Arthroplast."},{"key":"10.1016\/j.intimp.2023.109720_b0170","article-title":"Osteolysis: medical and surgical approaches","volume":"138\u2013147","author":"Saleh","year":"2004","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.intimp.2023.109720_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2010.05929.x","article-title":"Bisphosphonates and osteonecrosis of the jaw: proceedings of an international conference","volume":"1218","author":"Bilezikian","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.intimp.2023.109720_b0180","first-page":"497","article-title":"Long-term bisphosphonates for osteoporosis: a factor effecting fracture pattern","volume":"23","author":"Yaacobi","year":"2021","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.intimp.2023.109720_b0185","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00256-011-1164-9","article-title":"Bisphosphonates in the treatment of osteoporosis: a review of their contribution and controversies","volume":"40","author":"Reid","year":"2011","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.intimp.2023.109720_b0190","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/ki.2008.356","article-title":"Bisphosphonate nephrotoxicity","volume":"74","author":"Perazella","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2023.109720_b0195","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2010.195","article-title":"Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review","volume":"7","author":"Migliorati","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.intimp.2023.109720_b0200","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/jbmr.288","article-title":"Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort","volume":"26","author":"Kim","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.intimp.2023.109720_b0205","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1200\/JCO.2010.28.7524","article-title":"Atrial fibrillation and stroke associated with intravenous bisphosphonate therapy in older patients with cancer","volume":"28","author":"Wilkinson","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.intimp.2023.109720_b0210","first-page":"331","article-title":"Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients","volume":"7","author":"Yee","year":"2012","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.intimp.2023.109720_b0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","article-title":"Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment","volume":"127","author":"Nicolatou-Galitis","year":"2019","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.intimp.2023.109720_b0220","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.lpm.2015.12.010","article-title":"Denosumab: Lifetime treatment of osteoporosis?","volume":"45","author":"Laroche","year":"2016","journal-title":"Presse. Med."},{"key":"10.1016\/j.intimp.2023.109720_b0225","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1185\/03007995.2013.813840","article-title":"Incidence and risk of denosumab-related hypocalcemia in cancer patients: a systematic review and pooled analysis of randomized controlled studies","volume":"29","author":"Qi","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.intimp.2023.109720_b0230","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.beem.2018.09.005","article-title":"Postmenopausal osteoporosis: assessment and management","volume":"32","author":"Rizzoli","year":"2018","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2023.109720_b0235","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.2147\/DDDT.S200147","article-title":"Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events","volume":"13","author":"Subedi","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2023.109720_b0240","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.clinthera.2015.06.006","article-title":"The pathophysiology and treatment of osteoporosis","volume":"37","author":"Drake","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/j.intimp.2023.109720_b0245","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1111\/jcmm.14540","article-title":"Zingerone attenuates aortic banding-induced cardiac remodelling via activating the eNOS\/Nrf2 pathway","volume":"23","author":"Liu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2023.109720_b0250","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.919309","article-title":"Zingerone promotes osteoblast differentiation via MiR-200c-3p\/smad7 regulatory axis in human bone mesenchymal stem cells","volume":"26","author":"Song","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.intimp.2023.109720_b0255","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12272-015-0696-2","article-title":"Hepatoprotective effects of zingerone on carbon tetrachloride- and dimethylnitrosamine-induced liver injuries in rats","volume":"39","author":"Cheong","year":"2016","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.intimp.2023.109720_b0260","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/ptr.5435","article-title":"Zingerone activates VMAT2 during MPP(+) -induced cell death","volume":"29","author":"Choi","year":"2015","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2023.109720_b0265","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/biof.1515","article-title":"Osteogenic potential of zingerone, a phenolic compound in mouse mesenchymal stem cells","volume":"45","author":"Srinaath","year":"2019","journal-title":"Biofactors"},{"key":"10.1016\/j.intimp.2023.109720_b0270","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current understanding of RANK signaling in osteoclast differentiation and maturation","volume":"40","author":"Park","year":"2017","journal-title":"Mol. Cells"},{"key":"10.1016\/j.intimp.2023.109720_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2008.10.146","article-title":"NF-kappaB functions in osteoclasts","volume":"378","author":"Soysa","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2023.109720_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030499","article-title":"Gene expression in osteolysis: review on the identification of altered molecular pathways in preclinical and clinical studies","volume":"18","author":"Veronesi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109720_b0285","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11420-006-9003-6","article-title":"The central role of wear debris in periprosthetic osteolysis","volume":"2","author":"Purdue","year":"2006","journal-title":"HSS J."},{"key":"10.1016\/j.intimp.2023.109720_b0290","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1196\/annals.1365.035","article-title":"Bone remodeling","volume":"1092","author":"Hadjidakis","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.intimp.2023.109720_b0295","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00264-010-1143-0","article-title":"New animal models of wear-particle osteolysis","volume":"35","author":"Langlois","year":"2011","journal-title":"Int. Orthop."},{"key":"10.1016\/j.intimp.2023.109720_b0300","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/j.biomaterials.2004.10.020","article-title":"Role of hydroxyapatite coating in resisting wear particle migration and osteolysis around acetabular components","volume":"26","author":"Coathup","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2023.109720_b0305","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/00016470510030850","article-title":"Superior sealing effect of hydroxyapatite in porous-coated implants: experimental studies on the migration of polyethylene particles around stable and unstable implants in dogs","volume":"76","author":"Rahbek","year":"2005","journal-title":"Acta Orthop."},{"key":"10.1016\/j.intimp.2023.109720_b0310","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1186\/s12891-021-04458-4","article-title":"Zoledronic acid and teriparatide have a complementary therapeutic effect on aseptic loosening in a rabbit model","volume":"22","author":"Wang","year":"2021","journal-title":"BMC Musculoskel. Disord."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:11:50Z","timestamp":1736431910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":62,"alternative-id":["S1567576923000437"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109720","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zingerone attenuates Ti particle-induced inflammatory osteolysis by suppressing the NF-\u03baB signaling pathway in osteoclasts","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109720"}}